Search results for: PSC - AN12

NINDS Human Genetics Resource Center (2024)

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-155Funding Opportunity Title:Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:EducationHealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.393 -- Cancer Cause and Prevention ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Apr 12, 2023Last Updated Date:Apr 12, 2023Original Closing Date for Applications:May 07, 2026 Current Closing Date for Applications:May 07, 2026 Archive Date:Jun 12, 2026Estimated Total Program Funding: Award Ceiling: Award Floor: Document Type:Grants No...

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-204Funding Opportunity Title:NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:Cooperative AgreementCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.867 -- Vision ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:May 26, 2023Last Updated Date:May 26, 2023Original Closing Date for Applications:May 25, 2026 Current Closing Date for Applications:May 25, 2026 Archive Date:Jun 30, 2026Estimated Total Program Funding: Award Ceiling: Award Floor: Document Type:G...

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-193Funding Opportunity Title:Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthIncome Security and Social ServicesCategory Explanation: Expected Number of Awards: CFDA Number(s):93.865 -- Child Health and Human Development Extramural ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:May 19, 2023Last Updated Date:May 19, 2023Original Closing Date for Applications:Apr 03, 2026 Current Closing Date for Applications:Apr 03, 2026 Archive Date:May 09, 2026Estimated Total Program Funding: Award Ceiling: ...

Document Type:Grants NoticeFunding Opportunity Number:PAR-24-050Funding Opportunity Title:NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:Cooperative AgreementCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.173 -- Research Related to Deafness and Communication DisordersCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Oct 20, 2023Last Updated Date:Oct 20, 2023Original Closing Date for Applications:Oct 27, 2026 Current Closing Date for Applications:Oct 27, 2026 Archive Date:Dec 02, 2026Estimated Total Program Funding: Awa...

DESCRIPTIONThe purpose of the solicitation will be to recompete a NIAID resource entitled “EVALUATION AND TESTING SERVICES (ETSV) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES” that provides a suite of preclinical, non-clinical, and clinical testing services for vaccines and other biologic products. While the overall suite of testing services is comprehensive, the intent is to provide individual services on a case-by-case basis for a diverse collection of vaccine and biological product candidates, rather than carry a single product candidate through an entire preclinical development pathway. These services are intended to help a wide variety of investigators in a broad number of scientific areas obtain critical data needed to acq...

Limited muscle use is widespread in older adults (e.g., post-injury immobilization, bed rest) and typically leads to disuse-induced muscular atrophy defined by substantial loss of muscle mass, strength, and function [1- 3]. The overall health and functional independence of aging adults can rapidly and progressively deteriorate as muscle disuse causes atrophy and promotes a vicious cycle of further muscle disuse and subsequent exacerbated atrophy. Standard-of-care treatments to counter skeletal muscle atrophy include physical therapy and exercise [4], but these approaches have limited success in elderly populations [5]. Although pharmaceutical interventions to treat muscle loss are in development, many have unfavorable side effects. The only...